Golden State Medical Supply Inc. Carbamazepine Tablets, USP, 200mg Recall
Announced 2026-08-26 · FDA
Golden State Medical Supply Inc. is recalling Carbamazepine Tablets, USP, 200 mg, in 1000-count and 100-count bottles due to CGMP deviations with tablets containing black specks. The recall covers 1,200 bottles distributed nationwide in the United States and involves Lot GS067429, GS068091, Exp 5/31/2028 and Lot GS067430, GS068090, Exp 5/31/2028.
| Brand | Golden State Medical Supply Inc. |
|---|---|
| Product | Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA |
| Reason | CGMP deviations: tablets with black specks. |
| Severity | moderate |
| Units affected | 1200 |
| Distribution | USA Nationwide |
| Agency | FDA |
| Recall / campaign no. | Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028 |
WHAT YOU SHOULD DO
- Do not use this medication if it matches the listed lots.
- Check your bottle label for the lot numbers GS067429, GS068091 (1000-count bottles) or GS067430, GS068090 (100-count bottles) and Exp 5/31/2028 to determine if affected.
- Contact your pharmacist or prescriber for a replacement, refund, or disposal guidance.
- Follow any disposal or return instructions from the FDA or manufacturer.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.